Results 161 to 170 of about 54,372 (282)

The interleukin-1 beta 511C>T polymorphism is associated with susceptibility to juvenile idiopathic arthritis in a Turkish population. [PDF]

Rev Assoc Med Bras (1992)
Dogantan S, Oyaci Y, Cakmak F, Sayin SH, Kaplan EHA, Pehlivan S.   +5 more
europepmc   +1 more source

Approach to Nail Pitting in Pediatric and Adolescent Patients: A Dermatology Perspective

JEADV Clinical Practice, Volume 5, Issue 2, Page 394-401, June 2026.
ABSTRACT This narrative review aims to discuss the etiologies of nail pitting in pediatric and adolescent patients, while providing a framework for further evaluation of possible underlying systemic conditions and their clinical findings from a dermatologic standpoint.
Elizabeth Botto, Victoria Griffith, Samuel Stahly, Jere Mammino   +3 more
wiley   +1 more source

How can innovative trials in juvenile idiopathic arthritis serve the unmet needs of patients? [PDF]

Arthritis Res Ther
Bennett JL, Sen ES, Ramanan AV.
europepmc   +1 more source

Comorbidities and Treatment Patterns in People With Myasthenia Gravis in Denmark, Finland and Sweden: A Population‐Based Observational Study

Muscle &Nerve, Volume 73, Issue 6, Page 1044-1057, June 2026.
ABSTRACT Introduction/Aims Comorbidities are frequent in myasthenia gravis (MG) and may affect treatment choices. Conversely, MG treatments may impact the risk of comorbidity. Our objective was to examine comorbidity and MG treatment patterns in nationwide MG cohorts in Denmark, Finland, and Sweden. Methods We included individuals with ≥ 2 MG diagnoses
Sari Atula, Fredrik Piehl, Ingrid Schager, Fredrik Berggren, Karin Humle, Mari Savolainen, Didier Pitsi, Juha Mehtälä, Aino Vesikansa, Riina‐Minna Väänänen, Tero Ylisaukko‐oja, John Vissing   +11 more
wiley   +1 more source

Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept. [PDF]

Rheumatology (Oxford)
Chasnyk V, Constantin T, Nikishina I, Bader-Meunier B, Breda L, Doležalová P, Rumba-Rozenfelde I, Wulffraat N, Akikusa J, Avcin T, Burgos-Vargas R, Chaitow J, Carlini L, Tsekouras V, Graham D, Borlenghi C, Vlahos B, Zang C, Ruperto N.   +18 more
europepmc   +1 more source

Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD‐ON

Pediatric Pulmonology, Volume 61, Issue 6, June 2026.
ABSTRACT Background In the InPedILD trial, nintedanib had an acceptable safety profile in children and adolescents (aged 6−17 years) with fibrosing ILDs. The open‐label extension of the InPedILD trial, InPedILD‐ON, is assessing the longer‐term safety of nintedanib in these patients. Methods Patients who completed the InPedILD trial on treatment and had
Robin Deterding, Lisa R. Young, Emily M. DeBoer, David Warburton, Steven Cunningham, Nicolaus Schwerk, Kevin K. Brown, Václav Koucký, Jason P. Weinman, Jill Simmons, Mihaela Dumistracel, Frauke Jantzen, Martina Gahlemann, Matthias Griese, the InPedILD‐ON trial investigators   +14 more
wiley   +1 more source

Epidemiological study of the correlation and prevention of odontostomatological diseases in patients with Juvenile Idiopathic Arthritis

, 2016
AIM: The aim of this work was to test the knowledge about the correlation between juvenile idiopathic arthritis (JIA) and oral health and investigate on the wish of the individual about including the figure of the dental hygienist inside the JIA team at ...
V. Gerloni, C. Guarino, M. Gattinara, E. Dzsida, P. Cressoni, U. Garagiola, C. Occhipinti, M. Romano   +7 more
core  

Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scope. [PDF]

Rheumatol Adv Pract
Compeyrot-Lacassagne S, Beesley RP, Bray L, Bridges A, Chaplin H, Ciurtin C, Cleary G, Cooray S, Aragon Cuevas O, Cuthbert V, Deepak S, Earle E, Ferreira A, Kearsley-Fleet L, Gupta J, Houston R, Hum RM, Humphreys JH, Jayasekera HS, Jones S, MacFadyen C, Nisbet J, Arunath V, Prior Y, Rogers V, Shoop-Worrall SJW, Solebo AL, Waller R, Williamson LD, Wilson D, Wright C, Sen ES, British Society for Rheumatology Guideline Steering Group .   +32 more
europepmc   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang, Ngasin Lam, Xiaoming Huang, Yang Jiao   +3 more
wiley   +1 more source

Causal Effects of Rheumatoid Arthritis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis on Psoriasis: A Mendelian Randomization Study

Yongping Cao, Mengyun Zhou, Tianhong Xu Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou City, Zhejiang Province, People’s Republic of ChinaCorrespondence: Tianhong Xu, Department of Dermatology, Hangzhou Third People’s Hospital, 38 ...
Zhou M, Cao Y, Xu T
core